Is It Time for Polypill in Heart Failure Therapy? Current Preference among Indian Cardiologists: A Cross-sectional Survey

Background and Aim:Quadruple therapy plays a key role in heart failure (HF) management and the latest recommendation is “four pillar drugs on board in 4 weeks.” At present, there is no fixed-dose combination (FDC) of these foundational therapies existing in India. The present study aimed to understa...

Descripción completa

Detalles Bibliográficos

Autores principales:	Kamal Sharma, Ajay Pandey, Prafulla Kerkar, Sameer Shrivastava, Satyanarayan Routray, Smit Shrivastava, Aziz Khan, Preethi Naik, Nitin Zalte, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Akhil Sharma, Johann Christopher, Rohith Reddy
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2025-01-01
Colección:	Journal of the Practice of Cardiovascular Sciences
Materias:	arni beta-blockers heart failure quadruple therapy sodium-glucose cotransporter 2 inhibitors
Acceso en línea:	https://journals.lww.com/10.4103/jpcs.jpcs_46_24
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!